Abstract:Abstract Purpose: Breast cancer is one of the most common malignancies among women. The majority of cancer-associated deaths are caused by metastasis. Many biological alterations occur during this complex process, including the epithelial-mesenchymal transition (EMT), tumor immune escape, transendothelial migration (TEM). However, the biological mechanism of metastatic disease remains poorly understood and more need to be done to unify our understanding of underpinnings for metastasis in breast cancer. Methods: We performed functional screening with CRISPR-Cas9 Genome-Scale CRISPR Knock-Out (GeCKO) library to identify metastasis-associated genes in breast cancer. We confirmed the function of a set of genes by transwell assays to testify the efficacy of in vivo screening. Further, we conducted in vitro and in vivo assays to explore the mechanism of TMEM106A in suppressing metastasis of breast cancer. Results: The CRISPR-Cas9 library screening identified genes with potential of suppressing metastasis in breast cancer. Further validation of COPS2, SSBP2, TDG, DYRK4, GSG1, TMEM106A and PRR5L revealed that knock down of these genes promoted cell migration and invasion ability. In MDA-MB-231 and MDA-MB-468 cells, knock down of TMEM106A promoted in vitro migration, invasion, wound healing and in vivo pro-metastasis ability. In addition, E-cadherin was down-regulated and N-cadherin was up-regulated with suppression of TMEM106A. Accordingly, the potentiality of pro-metastasis was reversed when exogenous TMEM106A was expressed in MDA-MB-231 and MDA-MB-468 cells. We found the interaction between TMEM106A and WDR77 via Co-IP and MS analysis. Down-regulation of TMEM106A promoted expression of WDR77, which primarily occurred in the cytoplasm. To verify the association between TMEM106A and WDR77, we interfere WDR77 expression in MDA-MB-231 sg-TMEM106A, and the pro-metastasis effect of TMEM106A down-regulation was reversed. Discussion: CRISPR-Cas9 library screening is an effective strategy to identify genes associated with breast cancer metastasis. The positive selection provides us a set of genes with potentiality to repress migration and invasion. TMEM106A may suppress metastasis via influencing translocation of WDR77 in breast cancer. Citation Format: Yang L, Yu S-J, Shao Z-M. CRISPR-Cas9 screen identifies TMEM106A as a suppressor of breast cancer metastasis [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-01-16.

Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial-Mesenchymal Transition

CRMP4 Suppresses Cervical Cancer Cell Proliferation and EMT Through the Wnt/β-catenin Pathway

XBP1s Activates METTL3/METTL14 for ER-phagy and Paclitaxel Sensitivity Regulation in Breast Cancer

Single-cell Transcriptomic Profiling of Non-Hematopoietic Circulating Cells in Mid-Gestational Mouse Embryos.

YAP/TAZ Enhance P-body Formation to Promote Tumorigenesis

PCAF, ISX, and BRD4: a maleficent alliance serving lung cancer malignancy

Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1

Exclusion of NUMB Exon12 Controls Cancer Cell Migration through Regulation of Notch1-SMAD3 Crosstalk

Energy stress promotes P-bodies formation via lysine-63-linked polyubiquitination of HAX1

Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion

CBX4 Promotes Antitumor Immunity by Suppressing Pdcd1 Expression in T Cells.

The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms

YAP/TAZ enhances P-body formation to promote tumorigenesis

RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity

Targeting CREB-binding protein (CBP) abrogates colorectal cancer stemness through epigenetic regulation of C-MYC

Genome-wide identification and analysis of epithelial-mesenchymal transition-related RNA-binding proteins and alternative splicing in a human breast cancer cell line

Downregulation of nc886 contributes to prostate cancer cell invasion and TGFβ1-induced EMT

Abstract P2-01-16: CRISPR-Cas9 Screen Identifies TMEM106A As a Suppressor of Breast Cancer Metastasis

A p53/CPEB2 negative feedback loop regulates renal cancer cell proliferation and migration

CPEB2 m6A Methylation Regulates BTB Permeability via Affecting Splicing Factor SRSF5 Stability

Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb